PHARMA
MicuRx Expands Clinical Trial Program For Oral Antibiotic MRX-I
MicuRx Pharmaceuticals has initiated a global clinical development program for its lead compound MRX-I.
Takeda Terminates Development Of Fasiglifam
Takeda has decided to terminate the development activities for fasiglifam, an investigational treatment for type II diabetes, due to concerns about liver safety.
Sihuan Pharma, To-BBB Develop Brain Drug Delivery Technology
Sihuan Pharmaceutical has signed an agreement with to-BBB to combine drug compounds and brain drug delivery technology for a research study.
Senhwa Biosciences Raises US$17m For Cancer Clinical Trials
Senhwa Biosciences has raised an additional US$17 million in Series B financing to drive its anticancer agents through critical clinical trials.
ScinoPharm To Open Manufacturing Plant In Changshu, China
ScinoPharm has completed construction of its Changshu plant on a 16-acre site in China.
A*STAR, KHIDI Sign MOU For Scientific Collaboration
A*STAR and KHIDI have signed a MOU to symbolize their growing bilateral cooperation in the field of biomedical sciences.
Oral Proteasome Inhibitor Could Improve Multiple Myeloma Treatment
Takeda has announced clinical study results combining oral investigational MLN9708 with lenalidomide and dexamethasone, in patients with newly diagnosed multiple myeloma.
Teva, Takeda To Commercialize Multiple Sclerosis Drug
Teva and Takeda will jointly commercialize Teva’s glatiramer acetate formulation for the treatment of multiple sclerosis in Japan.
Swiss Pharma Helsinn Group Opens Chinese Unit
Helsinn Group, a Swiss pharmaceutical company that focuses on oncologic products, has opened a representative office in Beijing, China.
